Security key
G2851K104
Drugs Made In America Acquisition II Corp. - Ordinary Shares (DMII)
CUSIP: G2851K104
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Ordinary Shares
- Total 13F shares
- 45,479,691
- Total 13F value
- $457,571,530
- Share change
- +1,551,822
- SEC-reported price per share
- $10.06
- Number of holders
- 70
- Value change
- +$15,857,769
- Number of buys
- 21
- Number of sells
- 18
- Shares outstanding
- 65,767,971
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
70
Top holders
10
DMII full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Previous quarter: Q1 2026
Drugs Made In America Acquisition II Corp. SEC filings
Drugs Made In America Acquisition II Corp. company facts
Broader feeds
Reporting periods
Holder history for CUSIP G2851K104
Recent filing periods:
Ownership snapshot
Top reported holders of DMII - Drugs Made In America Acquisition II Corp. - Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Drugs Made In America Acq...
Disclosed value leader
Magnetar Financial LLC
Comparable rows
1/15
Latest evidence
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 10%
14 rows are not safely comparable across share classes.
13D/G row: Drugs Made In America Acquisition II LLC
Showing 1-6 of 15 holder rows.
Quick read
Drugs Made In America Acquisition II LLC leads the comparable SEC ownership view at 10%.
1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Drugs Made In America Acquisition II LLC's linked filing trail.
Comparable ownership
Top 1
Drugs Made In America Acquisition...
10%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Drugs Made In America Acquisition II LLC |
13D/G
3/4/5
10%+ Owner
|
10%
Reported 13D/G
· 01 Oct 2025
|
—
6,708,333 shares
|
$0 | 01 Oct 2025 |
| Lynn Stockwell |
3/4/5
CEO and Exe. Chair of Board, Director, 10%+ Owner
|
—
denominator unverified
|
—
6,708,333 shares
|
— | 26 Sep 2025 |
| Magnetar Financial LLC |
13F
Company
|
—
mixed-class rows
|
$27,162,000
5,400,000 shares
mixed-class rows
|
— | 31 Mar 2026 |
| MMCAP International Inc. SPC |
13F
Company
|
—
mixed-class rows
|
$27,135,000
5,400,000 shares
mixed-class rows
|
— | 31 Mar 2026 |
| Karpus Management, Inc. |
13F
Company
|
—
denominator unverified
|
$25,901,292
2,597,923 shares
|
— | 31 Mar 2026 |
| GLAZER CAPITAL, LLC |
13F
Company
|
—
mixed-class rows
|
$23,579,000
4,249,660 shares
mixed-class rows
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
70
Shares
45,479,691
Rows available
70
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
68
Q2 2026 holders
70
Holder diff
2
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend